Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD2 | Q9HC29 | 3/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | FNTA | P49354 | 6/20 | 0.45 |
| ▸ | FNTB | P49356 | 6/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30708803 | 1.00 | NOD2 (0.47) | NOD2NOD1MAPTFNTAFNTB | |
| SCHEMBL26931200 | 0.93 | FNTA (0.45) | NOD2NOD1MAPTFNTAFNTB | |
| SCHEMBL26931128 | 0.93 | FNTA (0.54) | NOD2NOD1MAPTFNTAFNTB | |
| SCHEMBL27165736 | 0.93 | FNTA (0.54) | NOD2NOD1MAPTFNTAFNTB | |
| SCHEMBL26930792 | 0.93 | FNTA (0.53) | NOD2NOD1MAPTFNTAFNTB | |
| SCHEMBL26930685 | 0.86 | MAPT (0.39) | NOD2NOD1MAPTFNTAFNTB | |
| SCHEMBL30708759 | 0.80 | ALDH1A1 (0.44) | NOD2NOD1MAPTFNTAFNTB | |
| SCHEMBL26931196 | 0.80 | ALDH1A1 (0.44) | NOD2NOD1MAPTFNTAFNTB | |
| SCHEMBL11715181 | 0.77 | KDM4E (0.50) | NOD2NOD1MAPTKDM4EALDH1A1 | |
| SCHEMBL27156298 | 0.74 | FNTA (0.53) | NOD2NOD1MAPTFNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11938120-B1 | Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents | King Faisal University (SA) | 2024-03-26 | — | — | US | claimed |
| US-11845746-B1 | Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents | King Faisal University (SA) | 2023-12-19 | — | — | US | claimed |
| US-11938120-B1 | Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents | King Faisal University (SA) | 2024-03-26 | — | — | US | disclosed |
| US-11845746-B1 | Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents | King Faisal University (SA) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11845746-B1 | Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents | BET1, RABGGTB, EP300 | NOD2 3065/4885NOD1 1212/4885MAPT 2304/4885 |
| US-11938120-B1 | Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents | BET1, RABGGTB, EP300 | NOD2 3048/4885NOD1 1273/4885MAPT 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.